The role of biomarkers in alcoholism medication trials

Alcoholism: Clinical and Experimental Research

Volumn 25, Issue 8, 2001, Pages 1119-1125

  Allen, John P ^a   Litten, Raye Z ^a   Strid, Nuria ^b   Sillanaukee, Pekka ^c  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NS Associates   (Sweden)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alcohol Treatment; Biochemical Markers; Biomarkers; Clinical Trial; Outcome Measures

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOCHEMICAL MARKER; CARBOHYDRATE DEFICIENT TRANSFERRIN; DRUG; GAMMA GLUTAMYLTRANSFERASE;

ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CLINICAL TRIAL; DRINKING BEHAVIOR; DRUG RESEARCH; DRUG SAFETY; HUMAN; LIVER FUNCTION TEST; MEAN CORPUSCULAR VOLUME; OUTCOMES RESEARCH; PRIORITY JOURNAL; PUBLICATION; SELF REPORT;

EID: 0034883689     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2001.tb02325.x     Document Type: Article

References (40)

1. Proposed recommendations for research on biochemical markers for problematic drinking
2. The role of laboratory tests in alcoholism treatment
3. Carbohydrate-deficient transferrin, γ-glutamyltransferase, and macrocytic volume as biomarkers of alcohol problems in women
4. Carbohydrate-deficient transferrin: An aid to early recognition of alcohol relapse
5. Contribution of carbohydrate deficient transferrin to gamma glutamyl transpeptidase in evaluating progress of patients in treatment for alcoholism
6. Biological assessment of alcohol consumption
7. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial
8. Effect of citalopram on alcohol intake in heavy drinkers
9. Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: A controlled study
10. A multicenter, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse
11. Disulfiram treatment of alcoholism
12. United Kingdom multicentre acamprosate study (UKMAS): A 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol
13. Bromocriptine in the treatment of alcohol dependence
14. Gamma-hydroxybutyric acid in the treatment of alcohol dependence: A double-blind study
15. Acamprosate and prevention of relapse in alcoholics
16. Utility of biological markers during outpatient treatment of alcohol-dependent subjects: Carbohydrate-deficient transferrin responds to moderate changes in alcohol consumption
17. Ritanserin in the treatment of alcohol dependence - A multi-center clinical trial
18. Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: A randomized controlled trial
19. Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: From hypotheses to preliminary clinical evidence
20. Acamprosate appears to decrease alcohol intake in weaned alcoholics
21. γ-glutamyltranspeptidase and carbohydrate deficient transferrin: Alternative measures of excessive alcohol consumption
22. A placebo-controlled trial of buspirone in anxious inpatient alcoholics
23. Buspirone in the treatment of alcohol dependence: A placebo-controlled trial
24. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence
25. Treatment outcome in alcoholism - A comparison of self-report and the biological markers carbohydrate-deficient transferrin and γ-glutamyl transferase
26. Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers
27. Enalapril effects on alcohol intake and other consummatory behaviors in alcoholics
28. Differential effects of viqualine on alcohol intake and other consummatory behaviors
29. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol
30. Is carbohydrate-deficient transferrin a specific marker for alcohol abuse? A study of patients with chronic viral hepatitis
31. Evaluation of the alcopath, a transdermal dosimeter for monitoring alcohol consumption
32. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme
33. Utility of carbohydrate deficient transferrin as a marker of relapse in alcoholic patients
34. L'acamprosate diminue-t-il l'appétence pour l'alcool chez l'alcoolique sévère?
35. Relapse prevention by acamprosate
36. Tiapride in the long-term management of alcoholics of anxious or depressive temperament
37. Transdermal alcohol measurement for estimation of blood alcohol concentration
38. Citalopram in the treatment of alcoholism: A double-blind placebo-controlled study
39. Naltrexone in the treatment of alcohol dependence
40. Naltrexone and alcohol dependence